Benefit of adjuvant chemotherapy in patients with T4 UICC II colon cancer

BACKGROUND: Colorectal cancer is the third most common cancer and a major cause of morbidity and mortality worldwide. Adjuvant chemotherapy is considered the standard of care in patients with UICC stage III colon cancer after R0 resection. Adjuvant therapy was not shown to be beneficial in patients...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Teufel, Andreas, Gerken, Michael, Hartl, Janine, Itzel, Timo, Fichtner-Feigl, Stefan, Stroszczynski, Christian, Schlitt, Hans Jürgen, Hofstädter, Ferdinand, Klinkhammer-Schalke, Monika
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4451874/
https://ncbi.nlm.nih.gov/pubmed/25985893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1404-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados